A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says The New York TimesAmylyx will remove ALS drug from the market after failed trial – The Washington Post The Washington PostAmylyx to Pull ALS Drug From Market After Failed Trial BloombergAmylyx to pull ALS drug from market, cut 70% of staff STATAmylyx to pull failed ALS drug Relyvrio from market, cut 70% of staffers FiercePharma